NewAmsterdam Pharma Co. NV (NAMS)
22.48
+0.21
(+0.94%)
USD |
NASDAQ |
Oct 07, 11:56
NewAmsterdam Pharma Max Drawdown (5Y) : 66.23% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 66.23% |
| August 31, 2026 | 66.23% |
| July 31, 2026 | 66.23% |
| June 30, 2026 | 66.23% |
| May 31, 2026 | 66.23% |
| April 30, 2026 | 66.23% |
| March 31, 2026 | 66.23% |
| February 28, 2026 | 66.23% |
| January 31, 2026 | 66.23% |
| December 31, 2025 | 66.23% |
| November 30, 2025 | 66.23% |
| October 31, 2025 | 66.23% |
| September 30, 2025 | 66.23% |
| August 31, 2025 | 66.23% |
| July 31, 2025 | 66.23% |
| June 30, 2025 | 66.23% |
| May 31, 2025 | 66.23% |
| April 30, 2025 | 66.23% |
| March 31, 2025 | 66.23% |
| February 28, 2025 | 66.23% |
| January 31, 2025 | 66.23% |
| December 31, 2024 | 66.23% |
| November 30, 2024 | 66.23% |
| October 31, 2024 | 66.23% |
| September 30, 2024 | 66.23% |
| Date | Value |
|---|---|
| August 31, 2024 | 66.23% |
| July 31, 2024 | 66.23% |
| June 30, 2024 | 66.23% |
| May 31, 2024 | 66.23% |
| April 30, 2024 | 66.23% |
| March 31, 2024 | 66.23% |
| February 29, 2024 | 66.23% |
| January 31, 2024 | 66.23% |
| December 31, 2023 | 66.23% |
| November 30, 2023 | 66.23% |
| October 31, 2023 | 66.23% |
| September 30, 2023 | 48.62% |
| August 31, 2023 | 41.78% |
| July 31, 2023 | 36.19% |
| June 30, 2023 | 36.19% |
| May 31, 2023 | 32.81% |
| April 30, 2023 | 29.98% |
| March 31, 2023 | 29.98% |
| February 28, 2023 | 29.98% |
| January 31, 2023 | 25.00% |
| December 31, 2022 | 25.00% |
| November 30, 2022 | 25.00% |
| October 31, 2022 | 10.55% |
| September 30, 2022 | 10.55% |
| August 31, 2022 | 10.55% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| ProQR Therapeutics NV | 97.50% |
| Pharming Group NV | 60.45% |
| argenx SE | 38.20% |
| Ionis Pharmaceuticals, Inc. | 70.27% |
| Arcutis Biotherapeutics, Inc. | 95.02% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 15.12 |
| Beta (5Y) | 0.0980 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 60.67% |
| Historical Sharpe Ratio (5Y) | 0.2654 |
| Historical Sortino (5Y) | 0.5716 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 20.10% |